{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:24:57Z","timestamp":1794479097907,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002790","name":"Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["NSERC-2020-04241"],"award-info":[{"award-number":["NSERC-2020-04241"]}],"id":[{"id":"10.13039\/501100002790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["Scholar Award 17686"],"award-info":[{"award-number":["Scholar Award 17686"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM126906"],"award-info":[{"award-number":["R35GM126906"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM128666"],"award-info":[{"award-number":["R35GM128666"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007259","name":"SUNY | Stony Brook University","doi-asserted-by":"publisher","award":["1149556"],"award-info":[{"award-number":["1149556"]}],"id":[{"id":"10.13039\/100007259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007259","name":"SUNY | Stony Brook University","doi-asserted-by":"publisher","award":["1149556"],"award-info":[{"award-number":["1149556"]}],"id":[{"id":"10.13039\/100007259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI136934"],"award-info":[{"award-number":["AI136934"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI116420"],"award-info":[{"award-number":["AI116420"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI125770"],"award-info":[{"award-number":["AI125770"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pathogenic fungi exhibit a heavy burden on medical care and new therapies are needed. Here, we develop the fungal specific enzyme sterylglucosidase 1 (Sgl1) as a therapeutic target. Sgl1 converts the immunomodulatory glycolipid ergosterol 3\u03b2-D-glucoside to ergosterol and glucose. Previously, we found that genetic deletion of Sgl1 in the pathogenic fungus <jats:italic>Cryptococcus neoformans<\/jats:italic> (<jats:italic>Cn<\/jats:italic>) results in ergosterol 3\u03b2-D-glucoside accumulation, renders <jats:italic>Cn<\/jats:italic> non-pathogenic, and immunizes mice against secondary infections by wild-type <jats:italic>Cn<\/jats:italic>, even in condition of CD4+ T cell deficiency. Here, we disclose two distinct chemical classes that inhibit Sgl1 function in vitro and in <jats:italic>Cn<\/jats:italic> cells. Pharmacological inhibition of Sgl1 phenocopies a growth defect of the <jats:italic>Cn \u0394sgl1<\/jats:italic> mutant and prevents dissemination of wild-type <jats:italic>Cn<\/jats:italic> to the brain in a mouse model of infection. Crystal structures of Sgl1 alone and with inhibitors explain Sgl1\u2019s substrate specificity and enable the rational design of antifungal agents targeting Sgl1.<\/jats:p>","DOI":"10.1038\/s41467-021-26163-5","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T10:25:59Z","timestamp":1633602359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Structure and inhibition of Cryptococcus neoformans sterylglucosidase to develop antifungal agents"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0901-6909","authenticated-orcid":false,"given":"Nivea","family":"Pereira de Sa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Taouil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reece M.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7904-9859","authenticated-orcid":false,"given":"John E.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-1161","authenticated-orcid":false,"given":"Iwao","family":"Ojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Del Poeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4981-1253","authenticated-orcid":false,"given":"Michael V.","family":"Airola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"26163_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","volume":"23","author":"BJ Park","year":"2009","unstructured":"Park, B. J. et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS. AIDS 23, 525\u2013530 (2009).","journal-title":"AIDS"},{"key":"26163_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37330-y","volume":"9","author":"LN Jeffreys","year":"2019","unstructured":"Jeffreys, L. N. et al. Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs. Sci. Rep. 9, 1577 (2019).","journal-title":"Sci. Rep."},{"key":"26163_CR3","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1073\/pnas.1117280109","volume":"109","author":"KC Gray","year":"2012","unstructured":"Gray, K. C. et al. Amphotericin primarily kills yeast by simply binding ergosterol. Proc. Natl Acad. Sci. USA 109, 2234\u20132239 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"26163_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nchembio.1496","volume":"10","author":"TM Anderson","year":"2014","unstructured":"Anderson, T. M. et al. Amphotericin forms an extramembranous and fungicidal sterol sponge. Nat. Chem. Biol. 10, 400\u2013406 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"26163_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrd.2017.46","volume":"16","author":"JR Perfect","year":"2017","unstructured":"Perfect, J. R. The antifungal pipeline: a reality check. Nat. Rev. Drug Discov. 16, 603\u2013616 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"26163_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/jof6010025","volume":"6","author":"TG Normile","year":"2020","unstructured":"Normile, T. G., McEvoy, K. & Del Poeta, M. Steryl glycosides in fungal pathogenesis: an understudied immunomodulatory adjuvant. J. Fungi (Basel) 6, 25 (2020).","journal-title":"J. Fungi (Basel)"},{"key":"26163_CR7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/yea.720","volume":"18","author":"T Sakaki","year":"2001","unstructured":"Sakaki, T. et al. Sterol glycosides and cerebrosides accumulate in Pichia pastoris, Rhynchosporium secalis and other fungi under normal conditions or under heat shock and ethanol stress. Yeast 18, 679\u2013695 (2001).","journal-title":"Yeast"},{"key":"26163_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.plipres.2010.02.001","volume":"49","author":"S Grille","year":"2010","unstructured":"Grille, S., Zaslawski, A., Thiele, S., Plat, J. & Warnecke, D. The functions of steryl glycosides come to those who wait: recent advances in plants, fungi, bacteria and animals. Prog. Lipid Res. 49, 262\u2013288 (2010).","journal-title":"Prog. Lipid Res."},{"key":"26163_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1126\/science.1064281","volume":"295","author":"L Peng","year":"2002","unstructured":"Peng, L., Kawagoe, Y., Hogan, P. & Delmer, D. Sitosterol-beta-glucoside as primer for cellulose synthesis in plants. Science 295, 147\u2013150 (2002).","journal-title":"Science"},{"key":"26163_CR10","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1074\/jbc.M114.616300","volume":"290","author":"T Watanabe","year":"2015","unstructured":"Watanabe, T. et al. Sterylglucoside catabolism in Cryptococcus neoformans with endoglycoceramidase-related protein 2 (EGCrP2), the first steryl-beta-glucosidase identified in fungi. J. Biol. Chem. 290, 1005\u20131019 (2015).","journal-title":"J. Biol. Chem."},{"key":"26163_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3389\/fmicb.2015.00836","volume":"6","author":"A Rella","year":"2015","unstructured":"Rella, A. et al. Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development. Front. Microbiol. 6, 836 (2015).","journal-title":"Front. Microbiol."},{"key":"26163_CR12","doi-asserted-by":"publisher","first-page":"14300","DOI":"10.1074\/jbc.M611455200","volume":"282","author":"ME Caines","year":"2007","unstructured":"Caines, M. E. et al. Structural and mechanistic analyses of endo-glycoceramidase II, a membrane-associated family 5 glycosidase in the Apo and GM3 ganglioside-bound forms. J. Biol. Chem. 282, 14300\u201314308 (2007).","journal-title":"J. Biol. Chem."},{"key":"26163_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1107\/S205979832000501X","volume":"76","author":"RJ Rowland","year":"2020","unstructured":"Rowland, R. J., Wu, L., Liu, F. & Davies, G. J. A baculoviral system for the production of human beta-glucocerebrosidase enables atomic resolution analysis. Acta Crystallogr. D Struct. Biol. 76, 565\u2013580 (2020).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"26163_CR14","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.str.2015.06.013","volume":"23","author":"MV Airola","year":"2015","unstructured":"Airola, M. V. et al. Structural basis for ceramide recognition and hydrolysis by human neutral ceramidase. Structure 23, 1482\u20131491 (2015).","journal-title":"Structure"},{"key":"26163_CR15","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1074\/jbc.M116.763821","volume":"292","author":"YB Han","year":"2017","unstructured":"Han, Y. B. et al. Structural insights into the broad substrate specificity of a novel endoglycoceramidase I belonging to a new subfamily of GH5 glycosidases. J. Biol. Chem. 292, 4789\u20134800 (2017).","journal-title":"J. Biol. Chem."},{"key":"26163_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2174\/138620708786734244","volume":"11","author":"DJ Urban","year":"2008","unstructured":"Urban, D. J. et al. Optimization and validation of two miniaturized glucocerebrosidase enzyme assays for high throughput screening. Comb. Chem. High. Throughput Screen 11, 817\u2013824 (2008).","journal-title":"Comb. Chem. High. Throughput Screen"},{"key":"26163_CR17","doi-asserted-by":"publisher","first-page":"e02909","DOI":"10.1128\/mBio.02909-18","volume":"10","author":"AC Colombo","year":"2019","unstructured":"Colombo, A. C. et al. Cryptococcus neoformans Glucuronoxylomannan and Sterylglucoside are required for host protection in an animal vaccination model. mBio 10, e02909\u2013e02918 (2019).","journal-title":"mBio"},{"key":"26163_CR18","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1016\/j.bmc.2014.09.034","volume":"22","author":"PR Markad","year":"2014","unstructured":"Markad, P. R. et al. gamma-Hydroxyethyl piperidine iminosugar and N-alkylated derivatives: a study of their activity as glycosidase inhibitors and as immunosuppressive agents. Bioorg. Med. Chem. 22, 5776\u20135782 (2014).","journal-title":"Bioorg. Med. Chem."},{"key":"26163_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bioorg.2015.06.006","volume":"62","author":"F Rahim","year":"2015","unstructured":"Rahim, F. et al. Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of alpha-glucosidase. Bioorg. Chem. 62, 15\u201321 (2015).","journal-title":"Bioorg. Chem."},{"key":"26163_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ejmech.2017.06.041","volume":"138","author":"F Ali","year":"2017","unstructured":"Ali, F. et al. Hydrazinyl arylthiazole based pyridine scaffolds: synthesis, structural characterization, in vitro alpha-glucosidase inhibitory activity, and in silico studies. Eur. J. Med. Chem. 138, 255\u2013272 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"26163_CR21","first-page":"1","volume":"9","author":"E Ortiz-Prado","year":"2019","unstructured":"Ortiz-Prado, E., Dunn, J. F., Vasconez, J., Castillo, D. & Viscor, G. Partial pressure of oxygen in the human body: a general review. Am. J. Blood Res. 9, 1\u201314 (2019).","journal-title":"Am. J. Blood Res."},{"key":"26163_CR22","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3389\/fmicb.2020.01920","volume":"11","author":"H Chung","year":"2020","unstructured":"Chung, H. & Lee, Y. H. Hypoxia: a double-edged sword during fungal pathogenesis? Front. Microbiol. 11, 1920 (2020).","journal-title":"Front. Microbiol."},{"key":"26163_CR23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10439-015-1415-3","volume":"44","author":"M Datta","year":"2016","unstructured":"Datta, M. et al. Mathematical model of oxygen transport in tuberculosis granulomas. Ann. Biomed. Eng. 44, 863\u2013872 (2016).","journal-title":"Ann. Biomed. Eng."},{"key":"26163_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/path.2055","volume":"210","author":"S Aly","year":"2006","unstructured":"Aly, S. et al. Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice. J. Pathol. 210, 298\u2013305 (2006).","journal-title":"J. Pathol."},{"key":"26163_CR25","first-page":"5","volume":"4","author":"K Zhang","year":"2011","unstructured":"Zhang, K., Zhu, L. & Fan, M. Oxygen, a key factor regulating cell behavior during neurogenesis and cerebral diseases. Front. Mol. Neurosci. 4, 5 (2011).","journal-title":"Front. Mol. Neurosci."},{"key":"26163_CR26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1365-2958.2007.05676.x","volume":"64","author":"YC Chang","year":"2007","unstructured":"Chang, Y. C., Bien, C. M., Lee, H., Espenshade, P. J. & Kwon-Chung, K. J. Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans. Mol. Microbiol. 64, 614\u2013629 (2007).","journal-title":"Mol. Microbiol"},{"key":"26163_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/apm.12647","volume":"125","author":"Q Kong","year":"2017","unstructured":"Kong, Q. et al. Transcriptomic and virulence factors analyses of Cryptococcus neoformans hypoxia response. APMIS 125, 236\u2013248 (2017).","journal-title":"APMIS"},{"key":"26163_CR28","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1128\/EC.00207-09","volume":"8","author":"YC Chang","year":"2009","unstructured":"Chang, Y. C., Ingavale, S. S., Bien, C., Espenshade, P. & Kwon-Chung, K. J. Conservation of the sterol regulatory element-binding protein pathway and its pathobiological importance in Cryptococcus neoformans. Eukaryot. Cell 8, 1770\u20131779 (2009).","journal-title":"Eukaryot. Cell"},{"key":"26163_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15124-z","volume":"11","author":"VI Khayyo","year":"2020","unstructured":"Khayyo, V. I. et al. Crystal structure of a lipin\/Pah phosphatidic acid phosphatase. Nat. Commun. 11, 1309 (2020).","journal-title":"Nat. Commun."},{"key":"26163_CR30","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1021\/jasms.0c00283","volume":"31","author":"JM Dobbs","year":"2020","unstructured":"Dobbs, J. M., Jenkins, M. L. & Burke, J. E. Escherichia coli and Sf9 contaminant databases to increase efficiency of tandem mass spectrometry peptide identification in structural mass spectrometry experiments. J. Am. Soc. Mass Spectrom. 31, 2202\u20132209 (2020).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"26163_CR31","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442\u2013D450 (2019).","journal-title":"Nucleic Acids Res."},{"key":"26163_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1006\/jmbi.1993.1012","volume":"229","author":"GD Van Duyne","year":"1993","unstructured":"Van Duyne, G. D., Standaert, R. F., Karplus, P. A., Schreiber, S. L. & Clardy, J. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J. Mol. Biol. 229, 105\u2013124 (1993).","journal-title":"J. Mol. Biol."},{"key":"26163_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1107\/S0021889809045701","volume":"43","author":"G Winter","year":"2009","unstructured":"Winter, G. xia2: an expert system for macromolecular crystallography data reduction. J. Appl. Crystallogr. 43, 186\u2013190 (2009).","journal-title":"J. Appl. Crystallogr."},{"key":"26163_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1107\/S2059798316002187","volume":"72","author":"DG Waterman","year":"2016","unstructured":"Waterman, D. G. et al. Diffraction-geometry refinement in the DIALS framework. Acta Crystallogr. D Struct. Biol. 72, 558\u2013575 (2016).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"26163_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"26163_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"26163_CR37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1107\/S0907444909012098","volume":"65","author":"TC Terwilliger","year":"2009","unstructured":"Terwilliger, T. C. et al. Decision-making in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol wizard. Acta Crystallogr. D Biol. Crystallogr. 65, 582\u2013601 (2009).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"26163_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1107\/S090744490705024X","volume":"64","author":"TC Terwilliger","year":"2008","unstructured":"Terwilliger, T. C. et al. Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr. D Biol. Crystallogr. 64, 61\u201369 (2008).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"26163_CR39","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"26163_CR40","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D Biol. Crystallogr. 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"26163_CR41","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"26163_CR42","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/jcc.23905","volume":"36","author":"WJ Allen","year":"2015","unstructured":"Allen, W. J. et al. DOCK 6: impact of new features and current docking performance. J. Comput. Chem. 36, 1132\u20131156 (2015).","journal-title":"J. Comput. Chem."},{"key":"26163_CR43","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1021\/ci1001982","volume":"50","author":"S Mukherjee","year":"2010","unstructured":"Mukherjee, S., Balius, T. E. & Rizzo, R. C. Docking validation resources: protein family and ligand flexibility experiments. J. Chem. Inf. Model 50, 1986\u20132000 (2010).","journal-title":"J. Chem. Inf. Model"},{"key":"26163_CR44","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"26163_CR45","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theory Comput"},{"key":"26163_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell, M. D. et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminformatics 4, 17 (2012).","journal-title":"J. Cheminformatics"},{"key":"26163_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open Babel: an open chemical toolbox. J. Cheminformatics 3, 33 (2011).","journal-title":"J. Cheminformatics"},{"key":"26163_CR48","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<553::AID-JCC3>3.0.CO;2-T","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren, T. A. Merck molecular force field. 3. Molecular geometries and vibrational frequencies for MMFF94. J. Comput. Chem. 17, 553\u2013586 (1996).","journal-title":"J. Comput. Chem."},{"key":"26163_CR49","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren, T. A. Merck molecular force field. 1. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 17, 490\u2013519 (1996).","journal-title":"J. Comput. Chem."},{"key":"26163_CR50","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<520::AID-JCC2>3.0.CO;2-W","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren, T. A. Merck molecular force field. 2. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J. Comput. Chem. 17, 520\u2013552 (1996).","journal-title":"J. Comput. Chem."},{"key":"26163_CR51","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<616::AID-JCC5>3.0.CO;2-X","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren, T. A. Merck molecular force field. 5. Extension of MMFF94 using experimental data, additional computational data, and empirical rules. J. Comput. Chem. 17, 616\u2013641 (1996).","journal-title":"J. Comput. Chem."},{"key":"26163_CR52","first-page":"587","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren, T. A. & Nachbar, R. B. Merck molecular force field. 4. Conformational energies and geometries for MMFF94. J. Comput. Chem. 17, 587\u2013615 (1996).","journal-title":"J. Comput. Chem."},{"key":"26163_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang, J. H., Chung, T. D. & Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen 4, 67\u201373 (1999).","journal-title":"J. Biomol. Screen"},{"key":"26163_CR54","unstructured":"CLSI. In Clinical and Laboratory Standards Institute. Vol. 28 (2008)."},{"key":"26163_CR55","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1462-5822.2011.01735.x","volume":"14","author":"A Singh","year":"2012","unstructured":"Singh, A. et al. Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans. Cell Microbiol. 14, 500\u2013516 (2012).","journal-title":"Cell Microbiol"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26163-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26163-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26163-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T15:55:51Z","timestamp":1669996551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26163-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["26163"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-26163-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.D.P. is a Co-Founder and Chief Scientific Officer (CSO) of MicroRid Technologies Inc. whose goal is to develop new antifungal agents of therapeutic use. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5885"}}